AKERO
Live / Registered — Registered (as of 15 Nov 2022)
What this means for you
Registered since 15 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88088292
- Registration number
- 6901415
- Mark type
- Stylized text
- Filed
- 22 Aug 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 15 Nov 2022
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders
Owner
- Akero Therapeutics, Inc., South San Francisco, CA, US
- Akero Therapeutics, Inc., South San Francisco, CA, US
- Akero Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 15 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Sept 2022 — USE AMENDMENT FILED
- 27 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 29 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2022 — SOU EXTENSION 5 GRANTED
- 25 Mar 2022 — SOU EXTENSION 5 FILED
- 25 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Dec 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Dec 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED